Novo's amycretin (GLP-1 + amylin) has shown 2224% weight loss in early studies potentially a new benchmark if Phase 3 results confirm

Here is an honest summary of what you can and cannot expect: What You CAN Realistically Expect Measurably softer, smoother skin texture within 34 weeks Visible reduction in fine lines, especially around the eyes, by weeks 48 Significantly firmer, more lifted-feeling skin by weeks 812 Reduced redness and improved skin tone uniformity from early weeks Improved healing of acne scarring, post-procedure recovery, and damaged skin A progressive, compounding improvement that continues building over months Hair thickness improvements with consistent scalp application over 812 weeks What You Should NOT Expect Dramatic wrinkle erasure in 12 weeks (those claims involve misleading photography or film-forming agents) Botox-equivalent muscle relaxation (GHK-Cu doesn't inhibit neurotransmitters that's Argireline/SNAP-8's role) Permanent results without ongoing use like all biological interventions, maintenance is required Identical results to someone else skin type, age, damage severity, and application consistency all affect outcomes GHK-Cu's results are directly proportional to consistency

It should be carefully based on the market to ensure competitiveness and room for discounting
Two people taking the same low dose of either medication may have completely different experiences based on their baseline metabolism, gut motility, hormonal environment, and sensitivity to receptor signaling
While beneficial for glucose control and weight loss, this slowed gastric emptying can increase the likelihood of gastric acid reflux, especially if the LES is weakened or functions abnormally